| 2021-09-16 | Sale | Sana Biotechnology, Inc. SANA | EVP, Head of Development & CMO | 1,627 0.0009% | $26.00 | $42,302 | -69.16% | |
| 2021-09-15 | Sale | Sana Biotechnology, Inc. SANA | EVP, Head of Development & CMO | 58,373 0.0323% | $26.07 | $1.52M | -69.32% | |
| 2016-07-21 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 649 0.0017% | $52.68 | $34,189 | +29.25% | |
| 2016-06-20 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 650 0.0017% | $54.16 | $35,204 | +23.04% | |
| 2016-05-24 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 650 0.0016% | $66.00 | $42,900 | +0.29% | |
| 2016-04-20 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 649 0.0017% | $70.53 | $45,774 | -1.9% | |
| 2016-03-22 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 650 0.0016% | $61.45 | $39,943 | +11.43% | |
| 2016-02-22 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 658 0.0017% | $63.48 | $41,770 | +6.37% | |
| 2016-01-20 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 585 0.0014% | $72.83 | $42,606 | -15.44% | |
| 2015-12-22 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 498 0.0013% | $114.81 | $57,175 | -41.72% | |
| 2015-11-23 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 498 0.0012% | $95.88 | $47,748 | -33.25% | |
| 2015-10-20 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 649 0.0017% | $85.51 | $55,496 | -21.41% | |
| 2015-09-22 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 498 0.0013% | $109.51 | $54,536 | -36.79% | |
| 2015-08-20 | Sale | Ultragenyx Pharmaceutical Inc. RARE | Chief Medical Officer | 17,020 0.0457% | $111.18 | $1.89M | -35.25% |